ID   UD18_RAT                Reviewed;         530 AA.
AC   Q64634;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   24-JUL-2024, entry version 136.
DE   RecName: Full=UDP-glucuronosyltransferase 1A8 {ECO:0000305};
DE            Short=UGT1A8;
DE            EC=2.4.1.17 {ECO:0000250|UniProtKB:Q9HAW9};
DE   AltName: Full=A3;
DE   AltName: Full=UDP-glucuronosyltransferase 1-8;
DE            Short=UDPGT 1-8;
DE            Short=UGT1*8;
DE            Short=UGT1-08;
DE            Short=UGT1.8;
DE   Flags: Precursor;
GN   Name=Ugt1a8 {ECO:0000312|RGD:708474}; Synonyms=Ugt1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Wistar;
RX   PubMed=7608130; DOI=10.1093/jb/117.2.392;
RA   Emi Y., Ikushiro S., Iyanagi T.;
RT   "Drug-responsive and tissue-specific alternative expression of multiple
RT   first exons in rat UDP-glucuronosyltransferase family 1 (UGT1) gene
RT   complex.";
RL   J. Biochem. 117:392-399(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 286-530.
RC   TISSUE=Liver;
RX   PubMed=2112380; DOI=10.1016/0006-291x(90)91462-2;
RA   Sato H., Koiwai O., Tanabe K., Kashiwamata S.;
RT   "Isolation and sequencing of rat liver bilirubin UDP-
RT   glucuronosyltransferase cDNA: possible alternate splicing of a common
RT   primary transcript.";
RL   Biochem. Biophys. Res. Commun. 169:260-264(1990).
CC   -!- FUNCTION: UDP-glucuronosyltransferase (UGT) that catalyzes phase II
CC       biotransformation reactions in which lipophilic substrates are
CC       conjugated with glucuronic acid to increase the metabolite's water
CC       solubility, thereby facilitating excretion into either the urine or
CC       bile. Essential for the elimination and detoxification of drugs,
CC       xenobiotics and endogenous compounds. Catalyzes the glucuronidation of
CC       endogenous steroid hormones such as androgens and estrogens. Produces
CC       dihydrotestosterone (DHT) diglucuronide from the DHT after two
CC       subsequent glucoronidation steps. Also catalyzes of the glucuronidation
CC       the isoflavones genistein, daidzein, glycitein, formononetin, biochanin
CC       A and prunetin, which are phytoestrogens with anticancer and
CC       cardiovascular properties. Involved in the glucuronidation of the AGTR1
CC       angiotensin receptor antagonist caderastan, a drug which can inhibit
CC       the effect of angiotensin II. {ECO:0000250|UniProtKB:Q9HAW9}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glucuronate acceptor + UDP-alpha-D-glucuronate = acceptor
CC         beta-D-glucuronoside + H(+) + UDP; Xref=Rhea:RHEA:21032,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:132367, ChEBI:CHEBI:132368; EC=2.4.1.17;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21033;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol + UDP-alpha-D-glucuronate = 17beta-estradiol
CC         3-O-(beta-D-glucuronate) + H(+) + UDP; Xref=Rhea:RHEA:52460,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16469, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:136641;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52461;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17alpha-estradiol + UDP-alpha-D-glucuronate = 17alpha-
CC         estradiol 3-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:52868, ChEBI:CHEBI:15378, ChEBI:CHEBI:17160,
CC         ChEBI:CHEBI:57529, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52869;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=estrone + UDP-alpha-D-glucuronate = estrone 3-O-(beta-D-
CC         glucuronate) + H(+) + UDP; Xref=Rhea:RHEA:52476, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17263, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:136634; Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52477;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=16alpha,17alpha-estriol + UDP-alpha-D-glucuronate =
CC         16alpha,17alpha-estriol 3-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:52924, ChEBI:CHEBI:15378, ChEBI:CHEBI:42156,
CC         ChEBI:CHEBI:58052, ChEBI:CHEBI:58223, ChEBI:CHEBI:136882;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52925;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxy-17beta-estradiol + UDP-alpha-D-glucuronate = 2-
CC         hydroxy-17beta-estradiol 3-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:53004, ChEBI:CHEBI:15378, ChEBI:CHEBI:28744,
CC         ChEBI:CHEBI:58052, ChEBI:CHEBI:58223, ChEBI:CHEBI:136931;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53005;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxy-17beta-estradiol + UDP-alpha-D-glucuronate = 17beta-
CC         estradiol 2-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:53032, ChEBI:CHEBI:15378, ChEBI:CHEBI:28744,
CC         ChEBI:CHEBI:58052, ChEBI:CHEBI:58223, ChEBI:CHEBI:136933;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53033;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxyestrone + UDP-alpha-D-glucuronate = 2-hydroxyestrone
CC         3-O-(beta-D-glucuronate) + H(+) + UDP; Xref=Rhea:RHEA:53048,
CC         ChEBI:CHEBI:1156, ChEBI:CHEBI:15378, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:136967;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53049;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-hydroxy-17beta-estradiol + UDP-alpha-D-glucuronate = 4-
CC         hydroxy-17beta-estradiol 3-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:53036, ChEBI:CHEBI:15378, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:62845, ChEBI:CHEBI:136936;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53037;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-hydroxy-17beta-estradiol + UDP-alpha-D-glucuronate = 17beta-
CC         estradiol 4-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:53040, ChEBI:CHEBI:15378, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:62845, ChEBI:CHEBI:136937;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53041;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-hydroxyestrone + UDP-alpha-D-glucuronate = 4-hydroxyestrone
CC         3-O-(beta-D-glucuronate) + H(+) + UDP; Xref=Rhea:RHEA:53052,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:87602, ChEBI:CHEBI:136969;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53053;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-hydroxyestrone + UDP-alpha-D-glucuronate = estrone 4-O-
CC         (beta-D-glucuronate) + H(+) + UDP; Xref=Rhea:RHEA:53060,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:87602, ChEBI:CHEBI:136970;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53061;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-methoxy-17beta-estradiol + UDP-alpha-D-glucuronate = 2-
CC         methoxy-17beta-estradiol 3-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:53072, ChEBI:CHEBI:15378, ChEBI:CHEBI:28955,
CC         ChEBI:CHEBI:58052, ChEBI:CHEBI:58223, ChEBI:CHEBI:136974;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53073;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-methoxyestrone + UDP-alpha-D-glucuronate = 2-methoxyestrone
CC         3-O-(beta-D-glucuronate) + H(+) + UDP; Xref=Rhea:RHEA:53064,
CC         ChEBI:CHEBI:1189, ChEBI:CHEBI:15378, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:136971;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53065;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-methoxy-17beta-estradiol + UDP-alpha-D-glucuronate = 4-
CC         methoxy-17beta-estradiol 3-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:53080, ChEBI:CHEBI:15378, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:136975, ChEBI:CHEBI:136976;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53081;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-methoxyestrone + UDP-alpha-D-glucuronate = 4-methoxyestrone
CC         3-O-(beta-D-glucuronate) + H(+) + UDP; Xref=Rhea:RHEA:53068,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:136972, ChEBI:CHEBI:136973;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53069;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-hydroxy-5alpha-androstan-3-one + UDP-alpha-D-
CC         glucuronate = 5alpha-dihydrotestosterone 17-O-(beta-D-glucuronate) +
CC         H(+) + UDP; Xref=Rhea:RHEA:53000, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16330, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:136914; Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53001;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5alpha-dihydrotestosterone 17-O-(beta-D-glucuronate) + UDP-
CC         alpha-D-glucuronate = 5alpha-dihydrotestosterone 17-O-[beta-D-
CC         glucuronosyl-(1->2)-glucuronate] + H(+) + UDP; Xref=Rhea:RHEA:53388,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:136914, ChEBI:CHEBI:136916;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53389;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=prunetin + UDP-alpha-D-glucuronate = prunetin-4'-O-beta-D-
CC         glucuronide + UDP; Xref=Rhea:RHEA:63588, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:147403, ChEBI:CHEBI:147404;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63589;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=prunetin + UDP-alpha-D-glucuronate = prunetin-5-O-beta-D-
CC         glucuronide + UDP; Xref=Rhea:RHEA:63612, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:147403, ChEBI:CHEBI:147405;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63613;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=candesartan + UDP-alpha-D-glucuronate = candesartan O-beta-D-
CC         glucuronoside + UDP; Xref=Rhea:RHEA:63724, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:149509, ChEBI:CHEBI:149522;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63725;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=mycophenolate + UDP-alpha-D-glucuronate = H(+) + mycophenolate
CC         7-O-beta-D-glucuronide + UDP; Xref=Rhea:RHEA:63704,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:62932, ChEBI:CHEBI:149486;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63705;
CC         Evidence={ECO:0000250|UniProtKB:Q9HAW9};
CC   -!- SUBUNIT: Homodimers. Homooligomer. Interacts with UGT1A1, UGT1A3,
CC       UGT1A4, UGT1A6, UGT1A7, UGT1A8, UGT1A9 and UGT1A10 to form
CC       heterodimers. {ECO:0000250|UniProtKB:Q9HAW9}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9HAW9}; Single-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=UGT1A8 is one of the isoforms produced at the UGT1A complex
CC         locus. The UGT1A complex locus produces different isoforms based on
CC         alternative use of promoters, first exons and terminal exons.
CC         {ECO:0000250|UniProtKB:Q9HAW9};
CC       Name=1;
CC         IsoId=Q64634-1; Sequence=Displayed;
CC   -!- SIMILARITY: Belongs to the UDP-glycosyltransferase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D38063; BAA07259.1; -; Genomic_DNA.
DR   EMBL; M34007; AAA42312.1; ALT_TERM; mRNA.
DR   AlphaFoldDB; Q64634; -.
DR   SMR; Q64634; -.
DR   CAZy; GT1; Glycosyltransferase Family 1.
DR   GlyCosmos; Q64634; 3 sites, No reported glycans.
DR   GlyGen; Q64634; 3 sites.
DR   PhosphoSitePlus; Q64634; -.
DR   PaxDb; 10116-ENSRNOP00000065158; -.
DR   UCSC; RGD:708474; rat. [Q64634-1]
DR   AGR; RGD:708474; -.
DR   RGD; 708474; Ugt1a8.
DR   eggNOG; KOG1192; Eukaryota.
DR   InParanoid; Q64634; -.
DR   PhylomeDB; Q64634; -.
DR   BRENDA; 2.4.1.17; 5301.
DR   Reactome; R-RNO-156588; Glucuronidation.
DR   Reactome; R-RNO-9749641; Aspirin ADME.
DR   Reactome; R-RNO-9753281; Paracetamol ADME.
DR   PRO; PR:Q64634; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0019899; F:enzyme binding; IBA:GO_Central.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; IDA:RGD.
DR   GO; GO:0052695; P:cellular glucuronidation; IBA:GO_Central.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0046226; P:coumarin catabolic process; IDA:RGD.
DR   GO; GO:0001889; P:liver development; IBA:GO_Central.
DR   GO; GO:0008202; P:steroid metabolic process; ISS:UniProtKB.
DR   CDD; cd03784; GT1_Gtf-like; 1.
DR   Gene3D; 3.40.50.2000; Glycogen Phosphorylase B; 2.
DR   InterPro; IPR050271; UDP-glycosyltransferase.
DR   InterPro; IPR002213; UDP_glucos_trans.
DR   InterPro; IPR035595; UDP_glycos_trans_CS.
DR   PANTHER; PTHR48043; EG:EG0003.4 PROTEIN-RELATED; 1.
DR   PANTHER; PTHR48043:SF157; UDP GLUCURONOSYLTRANSFERASE 1 FAMILY POLYPEPTIDE A3 PRECURSOR-RELATED; 1.
DR   Pfam; PF00201; UDPGT; 1.
DR   SUPFAM; SSF53756; UDP-Glycosyltransferase/glycogen phosphorylase; 1.
DR   PROSITE; PS00375; UDPGT; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Endoplasmic reticulum; Glycoprotein;
KW   Glycosyltransferase; Lipid metabolism; Membrane; Reference proteome;
KW   Signal; Transferase; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..530
FT                   /note="UDP-glucuronosyltransferase 1A8"
FT                   /id="PRO_0000036022"
FT   TRANSMEM        488..504
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        71
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        292
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        430
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   530 AA;  60060 MW;  507098AE81D4AC5C CRC64;
     MAPSGCPPSL PLCVCLFLAS GFAQAGRLLV VPMDGSHWFT MQMIVEKLSH RGHEVVVVIP
     EVSWHMGKSL NFTVKLLLVL NTLEDLNYHF KFFAHNQWKT QEVGMFSLLK HSGKGFFELL
     FSHCRSLFKD KKLVEYLKQS SFDAVFLDPF DVCGLILAKY FSLPSVVFSG GIFCHYLDEG
     AQCPSPPSYV PRILSKFTDT MTFKERVWNH LSYMKERAFC PYFFKTAVEI ASEVLQTPVT
     MRDLFSPVSI WMFRTDFVLE FPRPMMPNMV YIGGINCHQG KPLSKEFEAY VNASGEHGIV
     VFSLGSMVSE IPEKKAMEIA EALGRIPQTL LWRYTGTRPS NLAKNTILVK WLPQNDLLGH
     PKARAFITHS GSHGIYEGIC NGVPMVMMPL FGDQMDNAKR METRGAGVTL NVLEMTADDL
     ENALKTVINN KSYKENIMRL SSLHKDRPIE PLDLAVFWVE YVMRHKGAPH LRPAAHDLTW
     YQYHSLDVIG FLLAIVLTVV FIVYKSCAYG CRKCFGGKGR VKKSHKSKTH
//
